FDA Inspection 1180753 — Jim Bootsma Jr.
The FDA completed an inspection of Jim Bootsma Jr. on September 27, 2022 in Lakeview, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Lakeview, CA (United States)